Back to News
Market Impact: 0.3
INOVIO Prices $75 Mln Public Offering With Shares At $1.05 Each; Stock Down 21% Premarket
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
INOVIO Pharmaceuticals priced an underwritten public offering of common shares and pre-funded warrants, expecting approximately $75 million in gross proceeds. The equity financing provides capital but may dilute existing shareholders; the article gives no offering price or share-count details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
INO-0.30
More News
- Jefferies raises Inovio stock price target on regulatory win
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- FIGS Beats Earnings as Demand Outstrips Supply, CEO Trina Spear Says